FairJourney Bio
FairJourney Bio
About
FairJourney Bio (FJBio), The Antibody Company, is a global antibody discovery and engineering partner. Founded in 2012, the Company takes programs from target to preclinical candidate within a single integrated workflow, run by one team across three centers of excellence: Porto (Portugal),; Cambridge (UK); and San Diego (USA).
FJBio has completed more than 1,400 programs for over 250 industry partners across pharma, biotech, and academia, with 20 partner assets in clinical trials. Its team of more than 250 scientists, including over 60 PhDs in mAb antibody research, designs developability into each molecule from the first sequence, delivering advanceable leads rather than hits that still need fixing.
In 2024, Partners Group, one of the largest firms in the global private markets industry, invested in FJBio and supported the start of its US expansion.
The Company has since built a dedicated structural biology hub in San Diego, including in-house 300kV cryo-EM, to advance structure-guided antibody design under EU and US intellectual property and regulatory frameworks.
For more information, please visit: www.fjbio.com/
Get Updates
from LSPA
Stay up-to-date on the latest news and events from Life Sciences PA, insights from the life sciences industry, and so much more!
Life Sciences Pennsylvania was founded in 1989 by a biotech scientist at Penn State University. Today it has grown to represent the entire life sciences industry – biotechnology and diagnostic companies, medical device companies, pharmaceutical companies, investment organizations, research institutions, and myriad service industries that support the life sciences in Pennsylvania.